Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-13-000362

Options or other derivatives

  • Director acquired 150,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SAXE JON S Director 2013-03-03 Other acquisition · Warrant +150,000 150,000 D
Loading xslF345X03/form4-03062013_080344.xml…